Gfi-1 Activators belong to a class of chemical compounds associated with the modulation or enhancement of the biological activity of Growth Factor Independence 1 (Gfi-1), a transcriptional regulator and zinc finger protein. Gfi-1 is a crucial component of the cellular machinery responsible for controlling gene expression and plays a pivotal role in diverse biological processes, including hematopoiesis (the formation of blood cells), immune system development, and maintenance of tissue homeostasis. It functions as a transcriptional repressor, capable of binding to specific DNA sequences and recruiting co-repressor complexes to silence the expression of target genes. Gfi-1's transcriptional regulatory activities have significant implications for the differentiation, proliferation, and function of various cell types, particularly within the hematopoietic system.
Gfi-1 Activators are believed to interact with Gfi-1, influencing its DNA binding affinity, interactions with co-repressors or co-activators, or its subcellular localization. These interactions can result in the modulation of Gfi-1's transcriptional regulatory capabilities, impacting the expression of target genes and, consequently, cellular processes under its control. Research into Gfi-1 Activators and their effects on Gfi-1 function contributes to our understanding of the intricate gene regulatory networks that govern hematopoiesis, immune responses, and tissue development. It sheds light on the molecular mechanisms underlying the balance between cellular differentiation, proliferation, and maintenance and may have implications for a range of biological contexts beyond the hematopoietic system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can indirectly influence Gfi-1 activity by modulating Wnt signaling, a pathway known to interact with Gfi-1 related processes in hematopoiesis and oncogenesis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an inhibitor of MEK, may have an indirect effect on Gfi-1 through the MAPK/ERK pathway, which is involved in cellular proliferation and differentiation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, can indirectly affect Gfi-1 activity by modulating stress response and inflammatory pathways that are known to intersect with Gfi-1's regulatory network. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, potentially impacts Gfi-1 activity indirectly by affecting PI3K/Akt signaling, a pathway associated with cellular survival and proliferation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, through its ability to increase cAMP levels, might indirectly influence Gfi-1 activity by affecting various signaling pathways linked to cellular response and differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin may indirectly impact Gfi-1 through the mTOR signaling pathway, which is crucial in cell growth and proliferation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, might have an indirect effect on Gfi-1 by altering chromatin structure and gene expression patterns. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can potentially influence Gfi-1 activity indirectly by altering DNA methylation and gene expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, may indirectly affect Gfi-1 through the JNK signaling pathway, which is involved in stress response and apoptosis. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, could indirectly influence Gfi-1 activity by modulating the NF-κB pathway, linked to immune response and inflammation. | ||||||